SHIPping out diabetes—Metformin, an old friend among new SHIP2 inhibitors
Open Access
- 24 July 2019
- journal article
- review article
- Published by Wiley in Acta Physiologica
- Vol. 228 (1) , e13349
Abstract
SHIP2 (Src homology 2 domain containing inositol 5′‐phosphatase 2) belongs to the family of 5′‐phosphatases. It regulates the phosphoinositide 3‐kinase (PI3K)‐mediated insulin signaling cascade by dephosphorylating the 5′‐position of PtdIns(3,4,5)P3 to generate PtdIns(3,4)P2, suppressing the activity of the pathway. SHIP2 mouse models and genetic studies in human propose that increased expression or activity of SHIP2 contributes to the pathogenesis of the metabolic syndrome, hypertension and type 2 diabetes. This has raised great interest to identify SHIP2 inhibitors that could be used to design new treatments for metabolic diseases. This review summarizes the central mechanisms associated with the development of diabetic kidney disease, including the role of insulin resistance, and then moves on to describe the function of SHIP2 as a regulator of metabolism in mouse models. Finally, the identification of SHIP2 inhibitors and their effects on metabolic processes in vitro and in vivo are outlined. One of the newly identified SHIP2 inhibitors is metformin, the first‐line medication prescribed to patients with type 2 diabetes, further boosting the attraction of SHIP2 as a treatment target to ameliorate metabolic disorders.Keywords
This publication has 180 references indexed in Scilit:
- Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathyKidney International, 2012
- Septin 7 forms a complex with CD2AP and nephrin and regulates glucose transporter traffickingMolecular Biology of the Cell, 2012
- Defining the Contribution of AMP-activated Protein Kinase (AMPK) and Protein Kinase C (PKC) in Regulation of Glucose Uptake by Metformin in Skeletal Muscle CellsJournal of Biological Chemistry, 2012
- Cellular and molecular mechanisms of metformin: an overviewClinical Science, 2011
- AICAR and metformin, but not exercise, increase muscle glucose transport through AMPK-, ERK-, and PDK1-dependent activation of atypical PKCAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Discovery and functional characterization of a novel small molecule inhibitor of the intracellular phosphatase, SHIP2British Journal of Pharmacology, 2009
- Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathyAmerican Journal of Physiology-Renal Physiology, 2008
- Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factorKidney International, 2007
- The control of phosphatidylinositol 3,4-bisphosphate concentrations by activation of the Src homology 2 domain containing inositol polyphosphate 5-phosphatase 2, SHIP2Biochemical Journal, 2007
- Positionally Cloned Gene for a Novel Glomerular Protein—Nephrin—Is Mutated in Congenital Nephrotic SyndromeMolecular Cell, 1998